Inhibition of estrogen receptor alpha stabilizes regulatory T cell function in autoimmune hepatitis.

Zhang, L., Gromova, B., Nguyen, D. H., Cagle, C., Gomes, G. S., Li, W., Gao, L., Zhang, W., Graham, J. J., Wang, N., Kalbasi, A., Csizmadia, E., Wei, A., Cassavaugh, J., Bonder, A., Patwardhan, V., Jiang, S., Kota, S. K., & Longhi, M. S. (2026). Inhibition of estrogen receptor alpha stabilizes regulatory T cell function in autoimmune hepatitis.. JHEP Reports : Innovation in Hepatology, 8(2), 101678.

Abstract

BACKGROUND & AIMS: Regulatory T cell (Treg) dysfunction is a hallmark of autoimmune hepatitis (AIH), a serious hepatopathy often progressing to end-stage liver disease despite immunosuppression. Treg impairment in AIH has been linked to defective signaling through the aryl hydrocarbon receptor (AhR), a modulator of adaptive immunity. Herein, we investigated whether increased estrogen receptor alpha (ERα), an AhR non-canonical binding partner, impacts Treg immunity and contributes to the sex bias observed in AIH.

METHODS: Tregs were isolated from the peripheral blood of pre-menopausal, post-menopausal and male patients with AIH, as well as controls. Their function, stability, transcriptome and response to AhR were assessed in the absence or presence of methylpiperidinopyrazole (MPP), an ERα-selective antagonist. Therapeutic effects of MPP were tested in a model of Concanavalin-A-induced liver injury in humanized mice.

RESULTS: ERα was upregulated in Tregs from pre-menopausal females with AIH (1.1 ± 0.3) compared with healthy pre-menopausal females (0.4 ± 0.1; p = 0.038), and in pre-menopausal compared with post-menopausal females with AIH (0.3 ± 0.1; p = 0.04). In pre-menopausal females with AIH, MPP enhanced Treg suppressive capacity (2.5-fold increase; p = 0.001), restored response to AhR activation (2-fold increase; p = 0.03), and reduced functional plasticity, evidenced by decreased IL-17A and RORC expression under pro-inflammatory conditions. MPP also ameliorated Concanavalin-A-induced hepatitis in NOD/scid/gamma mice reconstituted with human CD4+ ERα+ cells, as shown by reduced ALT levels (101 ± 24 vs. 25 ± 8; p = 0.024), diminished hepatic inflammation on histology, and increased intrahepatic CD4+FOXP3+ and CD4+CD39+ T-cell frequencies. Bioinformatic and inhibition analyses identified hypoxia-inducible factor-1α as a key inducer of ERα in AIH Tregs.

CONCLUSIONS: ERα upregulation drives Treg dysfunction in pre-menopausal females with AIH and likely contributes to the sex bias in the disease. ERα blockade stabilizes Tregs and limits inflammation in vivo, representing a promising therapeutic strategy to enhance and sustain immune tolerance in AIH.

IMPACT AND IMPLICATIONS: Regulatory T cell (Treg) dysfunction plays a key role in the breakdown of immune tolerance in autoimmune hepatitis (AIH), a severe hepatopathy that often progresses to end-stage liver disease despite immunosuppression. Here we report that upregulation of estrogen receptor-alpha (ERα) alters Treg function and stability in pre-menopausal females with AIH, and that blockade of ERα using a specific antagonist stabilizes Tregs and curbs inflammation in humanized mice with liver injury. These findings implicate aberrant ERα signaling in the sex bias of AIH and support ERα inhibition as a potential therapeutic strategy to re-establish immune tolerance.

Last updated on 04/01/2026
PubMed